Meituan invests in DeepMap, a development and research company specializing in AI-powered biosensors.

According to the (Qichacha) app, recently, there has been a business change in Beijing ShenNapuSi Artificial Intelligence Technology Co., Ltd., with the addition of Meituan's Chengdu Longzhu Equity Investment Fund Partnership as a shareholder. According to Qichacha information, the company was established in 2019, with its business scope including: research and development of bio-chemical products technology; sales of intelligent instruments and meters; production of third-class medical devices; operation of third-class medical devices, etc. According to their official website, ShenNapuSi focuses on AI-enabled biosensor research and development.